FTO

FTO

Fat mass and obesity-associated gene (FTO) is a member of the Fe (II)- and oxoglutarate-dependent AlkB dioxygenase family and is linked to both obesity and intellectual disability. Previous research showed that FTO is essential for adipogenesis and energy homeostasis. In contrast to mice with overexpressed FTO, which resulted in obesity, FTO-deficient mice show postnatal growth retardation, reduced food intake, and a significant reduction of adipose tissue.

Additionally, the crucial roles that FTO plays in neurogenesis, learning, and memory may be connected to its function as an RNA demethylase of N6-methyladenosine (m6A). Additionally discovered to be highly abundant in the brain, FTO protein is linked to decreased brain volume in children and the elderly. In addition to affecting the dopamine receptor 2- and 3-dependent control of neuronal activity and locomotor behavioral responses, FTO gene deficiency increases the retention of fear memory.

FTO related products

Structure Cat No. Product Name CAS No. Product Description
V41317 FB23 2243736-35-6 FB23 is a novel, potent and selective inhibitor (IC50 of 60 nM) of FTO demethylase, an mRNA N6-methyladenosine (m6A) demethylase that was reported to promote leukemogenesis.
V2426 FTO-IN-1 2243944-92-3 FTO-IN-1 is an inhibitor (blocker/antagonist) of fat and obesity-related enzymes (FTO) with IC50 of <1 μM.
V74013 FTO-IN-1 TFA 2797619-81-7 FTO-IN-1 TFA is an inhibitor (blocker/antagonist) of fat and obesity-related enzymes (FTO) with IC50 of <1 μM.
V74012 FTO-IN-2 2585198-85-0 FTO-IN-2 is an FTO inhibitor that can suppress glioblastoma stem cell self-renewal.
V74014 FTO-IN-3 2585198-87-2 FTO-IN-3 is an FTO inhibitor that can suppress self-renewal of glioblastoma stem cells.
V74015 FTO-IN-4 2763577-74-6 FTO-IN-4 is a potent and specific inhibitor of fat mass and obesity-related proteins (FTO).
V74016 FTO-IN-5 2763577-75-7 FTO-IN-5 is a potent and specific inhibitor of fat mass and obesity-related proteins (FTO).
V74010 FTO-IN-6 2968347-63-7 FTO-IN-6 is a selective fat mass and obesity-associated protein (FTO) inhibitor.
V74011 N6,2′-O-Dimethyladenosine 57817-83-1 N6,2′-O-Dimethyladenosine, a substrate of fat mass and obesity-related genes (FTO), is a reversible modification widely present on various RNA molecules.
V78580 ZLD115 ZLD115 (compound 44) is an FB23-derived inhibitor of fat mass and obesity-related proteins (FTO).
Contact Us Back to top